The synthesis and structure of heteroleptic tris(diimine)ruthenium(II) complexes

The reactions of bidentate diimine ligands (L2) with cationic bis(diimine)[Ru(L)(L1)(CO)Cl]+ complexes (L, L1, L2 are dissimilar diimine ligands), in the presence of trimethylamine-N-oxide (Me3NO) as a decarbonylation reagent, lead to the formation of heteroleptic tris(diimine) ruthenium(II) complexes, [Ru(L)(L1)(L2)]2+. Typically isolated as hexafluorophosphate or perchlorate salts, these complexes were characterised by UV-visible, infrared and mass spectroscopy, cyclic voltammetry, microanalyses and NMR spectroscopy. Single crystal X-ray studies have elucidated the structures of K[Ru(bpy)(phen)(4,4'-Me(2)bpy)](PF(6))(3).1/2H(2)O, [Ru(bpy)(5,6-Me(2)phen)(Hdpa)](ClO(4))(2), [Ru(bpy)(phen)(5,6-Me(2)phen)](ClO(4))(2), [Ru(bpy)(5,6'-Me(2)phen)(4,4'-Me(2)bpy)](PF(6))(2).EtOH, [Ru(4,4'-Me(2)bpy)(phen)(Hdpa)](PF(6))(2).MeOH and [Ru(bpy)(4,4'-Me(2)bpy)(Hdpa)](ClO(4))(2).1/2Hdpa (where Hdpa is di(2-pyridyl)amine). A novel feature of the first complex is the presence of a dinuclear anionic adduct, [K(2)(PF(6))(6)](4-), in which the two potassium centres are bridged by two fluorides from different hexafluorophosphate ions forming a K(2)F(2) bridging unit and by two KFPFK bridging moieties.     

cis-Bis(bipyridine)ruthenium Imidazole Derivatives: A Spectroscopic, Kinetic, and Structural Study

The ruthenium bis(bipyridine) complexes cis-[Ru(bpy)(2)Im(OH(2))](2+), cis-[Ru(bpy)(2)(Im)(2)](2+), cis-[Ru(bpy)(2)(N-Im)(2)](2+), cis-[Ru(dmbpy)(2)Im(OH(2))](2+), cis-[Ru(dmbpy)(2)(N-Im)(OH(2))](2+)(bpy = 2,2'-bipyridine, dmbpy = 4,4'-dimethyl-2,2'-bipyridine, Im = imidazole, N-Im = N-methylimidazole), have been synthesized under ambient conditions in aqueous solution (pH 7). Their electrochemical and spectroscopic properties, absorption, emission, and lifetimes were determined and compared. The substitution kinetics of the cis-[Ru(bpy)(2)Im(OH(2))](2+) complexes show slower rates and have lower affinities for imidazole ligands than the corresponding cis-[Ru(NH(3))(4)Im(OH(2))](2+) complexes. The crystal structures of the monoclinic cis-[Ru(bpy)(2)(Im)(2)](BF(4))(2), space group = P2(1)/a, Z = 4, a = 11.344(1) ?, b = 17.499(3) ?, c = 15.114(3) ?, and beta = 100.17(1) degrees, and triclinic cis-[Ru(bpy)(2)(N-Im)(H(2)O)](CF(3)COO)(2).H(2)O, space group = P&onemacr;, Z = 2, a = 10.432(4) ?, b = 11.995(3) ?, c = 13.912(5) ?, alpha = 87.03(3) degrees, beta = 70.28(3) degrees, and gamma = 71.57(2) degrees, complexes show that these molecules crystallize as complexes of octahedral Ru(II) to two bidentate bipyridine ligands with two imidazole ligands or a water and an N-methylimidazole ligand cis to each other. The importance of these molecules is associated with their frequent use in the modification of proteins at histidine residues and in comparisons of the modified protein derivatives with these small molecule analogs.     

Reactions of acetonitrile coordinated to a nitrosylruthenium complex with H2O or CH(3)OH under mild conditions: structural characterization of imido-type complexes

The reaction of cis-[Ru(NO)(CH(3)CN)(bpy)(2)](3+) (bpy = 2,2'-bipyridine) in H(2)O at room temperature proceeded to afford two new nitrosylruthenium complexes. These complexes have been identified as nitrosylruthenium complexes containing the N-bound methylcarboxyimidato ligand, cis-[Ru(NO)(NH=C(O)CH(3))(bpy)(2)](2+), and methylcarboxyimido acid ligand, cis-[Ru(NO)(NH=C(OH)CH(3))(bpy)(2)](3+), formed by an electrophilic reaction at the nitrile carbon of the acetonitrile coordinated to the ruthenium ion. The X-ray structure analysis on a single crystal obtained from CH(3)CN-H(2)O solution of cis-[Ru(NO)(NH=C(O)CH(3))(bpy)(2)](PF(6))(3) has been performed: C(22)H(20.5)N(6)O(2)P(2.5)F(15)Ru, orthorhombic, Pccn, a = 15.966(1) A, b = 31.839(1) A, c = 11.707(1) A, V = 5950.8(4) A(3), and Z = 8. The structural results revealed that the single crystal consisted of 1:1 mixture of cis-[Ru(NO)(NH=C(O)CH(3))(bpy)(2)](2+) and cis-[Ru(NO)(NH=C(OH)CH(3))(bpy)(2)](3+) and the structural formula of this single crystal was thus [Ru(NO)(NH=C(OH(0.5))CH(3))(bpy)(2)](PF(6))(2.5). The reaction of cis-[Ru(NO)(CH(3)CN)(bpy)(2)](3+) in dry CH(3)OH-CH(3)CN at room temperature afforded a nitrosylruthenium complex containing the methyl methylcarboxyimidate ligand, cis-[Ru(NO)(NH=C(OCH(3))CH(3))(bpy)(2)](3+). The structure has been determined by X-ray structure analysis: C(25)H(29)N(8)O(18)Cl(3)Ru, monoclinic, P2(1)/c, a = 13.129(1) A, b = 17.053(1) A, c = 15.711(1) A, beta = 90.876(5) degrees, V = 3517.3(4) A(3), and Z = 4.     

Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes

The tetradentate ligands 1,8-bis(pyrid-2-yl)-3,6-dithiaoctane (pdto) and 1,8-bis(benzimidazol-2-yl)-3,6-dithiaoctane (bbdo) form the complexes [Ru(pdto)(mu-Cl)](2)(ClO(4))(2) 1 and [Ru(bbdo)(mu-Cl)](2)(ClO(4))(2) 2 respectively. The new di-mu-chloro dimers 1 and 2 undergo facile symmetrical bridge cleavage reactions with the diimine ligands 2,2'-bipyridine (bpy) and dipyridylamine (dpa) to form the six-coordinate complexes [Ru(pdto)(bpy)](ClO(4))(2) 3, [Ru(bbdo)(bpy)](ClO(4))(2) 4, [Ru(pdto)(dpa)](ClO(4))(2) 5 and [Ru(bbdo)(dpa)](ClO(4))(2) 6 and with the triimine ligand 2,2':6,2'-terpyridine (terpy) to form the unusual seven-coordinate complexes [Ru(pdto)(terpy)](ClO(4))(2) 7 and [Ru(bbdo)(terpy)](ClO(4))(2) 8. In 1 the dimeric cation [Ru(pdto)(mu-Cl)](2)(2+) is made up of two approximately octahedrally coordinated Ru(II) centers bridged by two chloride ions, which constitute a common edge between the two Ru(II) octahedra. Each ruthenium is coordinated also to two pyridine nitrogen and two thioether sulfur atoms of the tetradentate ligand. The ligand pdto is folded around Ru(II) as a result of the cis-dichloro coordination, which corresponds to a "cis-alpha" configuration [DeltaDelta/LambdaLambda(rac) diastereoisomer] supporting the possibility of some attractive pi-stacking interactions between the parallel py rings at each ruthenium atom. The ruthenium atom in the complex cations 3a and 4 exhibit a distorted octahedral coordination geometry composed of two nitrogen atoms of the bpy and the two thioether sulfur and two py/bzim nitrogen atoms of the pdto/bbdo ligand, which is actually folded around Ru(II) to give a "cis-alpha" isomer. The molecule of complex 5 contains a six-coordinated ruthenium atom chelated by pdto and dpa ligands in the expected distorted octahedral fashion. The (1)H and (13)C NMR spectral data of the complexes throw light on the nature of metal-ligand bonding and the conformations of the chelate rings, which indicates that the dithioether ligands maintain their tendency to fold themselves even in solution. The bis-mu-chloro dimers 1 and 2 show a spin-allowed but Laporte-forbidden t(2g)(6)((1)A(1g))--> t(2g)(5) e(g)(1)((1)T(1g), (1)T(2g)) d-d transition. They also display an intense Ru(II) dpi--> py/bzim (pi*) metal-to-ligand charge transfer (MLCT) transition. The mononuclear complexes 3-8 exhibit dpi-->pi* MLCT transitions in the range 340-450 nm. The binuclear complexes 1 and 2 exhibit a ligand field ((3)MC) luminescence even at room temperature, whereas the mononuclear complexes 3 and 4 show a ligand based radical anion ((3)MLCT) luminescence. The binuclear complexes 1 and 2 undergo two successive oxidation processes corresponding to successive Ru(II)/Ru(III) couples, affording a stable mixed-valence Ru(II)Ru(III) state (K(c): 1, 3.97 x 10(6); 2, 1.10 x 10(6)). The mononuclear complexes 3-7 exhibit only one while 8 shows two quasi-reversible metal-based oxidative processes. The coordinated 'soft' thioether raises the redox potentials significantly by stabilising the 'soft' Ru(II) oxidation state. One or two ligand-based reduction processes were also observed for the mononuclear complexes.     

Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity

The paper reports the synthesis and characterisation of a series of flexible di-bidentate bridging ligands in which two 4-methyl-2,2'-bipyridine groups are linked at the 4'-position by polymethylene (bb(n)), linear polyether (bbO(n)) or linear alkylamine (bbN(n)) chains of varying length (n). The enantiomers (ΔΔ/ΛΛ) of the rac forms of the ruthenium(ii) dinuclear complexes incorporating these ligands -i.e. [{Ru(phen)(2)}(2)(μ-BL)](4+) (phen = 1,10-phenanthroline; BL = bb(n), bbO(n) or bbN(n)) - have been isolated by reaction of Δ- or Λ-[Ru(phen)(2)(py)(2)](2+) (py = pyridine) with the respective bridging ligands. Mononuclear species - in which only one of the bidentate moieties of the bridging ligand is coordinated - have also been isolated, as well as trinuclear and tetranuclear species involving the bb(7) bridge. Fluorescence displacement studies of the DNA-binding of the dinuclear complexes containing the bbO(n) and bbN(n) bridges generally revealed a lower affinity than their bb(n) analogues for an oligonucleotide containing a single bulge site; the mononuclear complexes showed a lower affinity - and the trinuclear and tetranuclear complexes a higher affinity - than the dinuclear species, revealing an interesting interplay of lipophilicity, electrostatics and size in the complex/nucleic acid interaction. Cytotoxicity studies of these complexes against a murine leukaemia cell line revealed that the presence of the polyether or polyamine links in the chain lowered the cytotoxicity compared with their polymethylene analogues, and that the bb(7)-bridged trinuclear and tetranuclear complexes showed considerably enhanced cytotoxicity compared with the dinuclear Rubb(7) analogue.     

Mono- and dinuclear ruthenium(II) 1,6,7,12-tetraazaperylene complexes

We report the synthesis of free 1,6,7,12-tetraazaperylene (tape). Tape was obtained from 1,1'-bis-2,7-naphthyridine by potassium promoted cyclization followed by oxidation with air. Mono- and dinuclear ruthenium(II) 1,6,7,12-tetraazaperylene complexes of the general formulas [Ru(L-L)(2)(tape)](PF(6))(2), [1](PF(6))(2)-[5](PF(6))(2), and [{Ru(L-L)(2)}(2)(μ-tape)](PF(6))(4), [6](PF(6))(4)-[10](PF(6))(4), with{L-L = phen, bpy, dmbpy (4,4'-dimethyl-2,2'-bipyridine), dtbbpy (4,4'-ditertbutyl-2,2'-bipyridine) and tmbpy (4,4'5,5'-tetramethyl-2,2'-bipyridine)}, respectively, were synthesized. The X-ray structures of tape·2CHCl(3) and the mononuclear complexes [Ru(bpy)(2)(tape)](PF(6))(2)·0.5CH(3)CN·0.5toluene, [Ru(dmbpy)(2)(tape)](PF(6))(2)·2toluene and [Ru(dtbbpy)(2)(tape)](PF(6))(2)·3acetone·0.5H(2)O were solved. The UV-vis absorption spectra and the electrochemical behavior of the ruthenium(ii) tape complexes were explored and compared with the data of the analogous dibenzoeilatin (dbneil), 2,2'-bipyrimidine (bpym) and tetrapyrido[3,2-a:2',3'-c:3',2'-h:2',3'-j]phenazin (tpphz) species.     

Study of the ligand substitution reactions of cis,cis-[(bpy)(2)(L)RuORu(L')(bpy)(2)](n+) (L,L' = H(2)O,OH(-), NH(3)) using electrospray ionization mass spectrometry and (1)H NMR

We have successfully applied electrospray ionization mass spectrometry (ESI-MS) and (1)H NMR analyses to study ligand substitution reactions of mu-oxo ruthenium bipyridine dimers cis,cis-[(bpy)(2)(L)RuORu(L')(bpy)(2)](n+) (bpy = 2,2'-bipyridine; L and L' = NH(3), H(2)O, and HO(-)) with solvent molecules, that is, acetonitrile, methanol, and acetone. The results clearly show that the ammine ligand is very stable and was not substituted by any solvents, while the aqua ligand was rapidly substituted by all the solvents. In acetonitrile and acetone solutions, the substitution reaction of the aqua ligand(s) competed with a deprotonation reaction from the ligand. The hydroxyl ligand was not substituted by acetonitrile or acetone, but it exchanged slowly with CH(3)O(-) in methanol. The substitution reaction of the aqua ligands in [(bpy)(2)(H(2)O)Ru(III)ORu(III)(H(2)O)(bpy)(2)](4+) was more rapid than that of the hydroxyl ligand in [(bpy)(2)(H(2)O)Ru(III)ORu(IV)(OH)(bpy)(2)](4+). In methanol, slow reduction of Ru(III) to Ru(II) was observed in all the mu-oxo dimers, and the Ru-O-Ru bridge was then cleaved to give mononuclear Ru(II) complexes.     

Ruthenium(II) coordination chemistry of a fused donor-acceptor ligand: synthesis, characterization, and photoinduced electron-transfer reactions of [{Ru(bpy)2}(n)(TTF-ppb)](PF6)(2n) (n = 1, 2)

A pi-extended, redox-active bridging ligand 4',5'-bis(propylthio)tetrathiafulvenyl[i]dipyrido[2,3-a:3',2'-c]phenazine (L) was prepared via direct Schiff-base condensation of the corresponding diamine-tetrathiafulvalene (TTF) precursor with 4,7-phenanthroline-5,6-dione. Reactions of L with [Ru(bpy)(2)Cl(2)] afforded its stable mono- and dinuclear ruthenium(II) complexes 1 and 2. They have been fully characterized, and their photophysical and electrochemical properties are reported together with those of [Ru(bpy)(2)(ppb)](2+) and [Ru(bpy)(2)(mu-ppb)Ru(bpy)(2)](4+) (ppb = dipyrido[2,3-a:3',2'-c]phenazine) for comparison. In all cases, the first excited state corresponds to an intramolecular TTF --> ppb charge-transfer state. Both ruthenium(II) complexes show two strong and well-separated metal-to-ligand charge-transfer (MLCT) absorption bands, whereas the (3)MLCT luminescence is strongly quenched via electron transfer from the TTF subunit. Clearly, the transient absorption spectra illustrate the role of the TTF fragment as an electron donor, which induces a triplet intraligand charge-transfer state ((3)ILCT) with lifetimes of approximately 200 and 50 ns for mono- and dinuclear ruthenium(II) complexes, respectively.     

Di- and tetranuclear ruthenium(II) and/or osmium(II) complexes of polypyridyl ligands bridged by a fully conjugated aromatic spacer: synthesis,characterization, and electrochemical and photophysical studies

A series of mono-, di-, and tetranuclear homo/heterometallic complexes of Ru(II) and Os(II) based on the bridging ligand dppz(11-11')dppz (where dppz = dipyrido[3,2-a:2',3'-c]phenazine) (BL) have been synthesized and characterized. This bridging ligand is a long rigid rod with only one rotational degree of freedom and provides complete conjugation between the chromophores. The complexes synthesized are of general formula [(bpy)(2)Ru-BL](2+), [(phen)(2)/(bpy)(2)M-BL-M(bpy)(2)/(phen)(2)](4+) (M = Ru(II) and Os(II)), [(bpy)(2)Ru-BL-Os(bpy)(2)](4+), and [((bpy)(2)Ru-BL)(3)M](8+). Detailed (1)H NMR studies of these complexes revealed that each chiral center does not influence its neighbor because of the long distance between the metal centers and the superimposed resonances of the diastereoisomers, which allowed the unambiguous assignment of the signals, particularly for homonuclear complexes. Concentration-dependent (1)H NMR studies show molecular aggregation of the mono- and dinuclear complexes in solution by pi-pi stacking. Electrospray mass spectrometry data are consistent with dimerization of mono- and dinuclear complexes in solution. Electrochemical studies show oxidations of Ru(II) and Os(II) in the potential ranges +1.38 to +1.40 and +0.92 to +1.01 V, respectively. The bridging ligand exhibits two one-electron reductions, and it appears that the added electrons are localized on the phenazene moieties of the spacer. All of these complexes show strong metal-to-ligand charge-transfer (MLCT) absorption and (3)MLCT luminescence at room temperature. Quantum yields have been calculated, and the emission lifetimes of all complexes have been measured by laser flash photolysis experiments. The luminescence intensity and lifetime data suggest that the emission due to the Ru center of the heteronuclear complexes is strongly quenched (>90%) compared to that of the corresponding model complexes. This quenching is attributed to intramolecular energy transfer from the Ru(II) center to the Os(II) center (k = (3-5) x 10(7) s(-1)) across the bridging ligand.     

Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes

In search of potential anticancer drug candidates in ruthenium complexes, a series of mononuclear ruthenium complexes of the type [Ru(phen)(2)(nmit)]Cl(2) (Ru1), [Ru(bpy)(2)(nmit)]Cl(2) (Ru2), [Ru(phen)(2)(icpl)]Cl(2) (Ru3), Ru(bpy)(2)(icpl)]Cl(2) (Ru4) (phen=1,10-phenanthroline; bpy=2,2'-bipyridine; nmit=N-methyl-isatin-3-thiosemicarbazone, icpl=isatin-3-(4-Cl-phenyl)thiosemicarbazone) and [Ru(phen)(2)(aze)]Cl(2) (Ru5), [Ru(bpy)(2)(aze)]Cl(2) (Ru6) (aze=acetazolamide) and [Ru(phen)(2)(R-tsc)](ClO(4))(2) (R=methyl (Ru7), ethyl (Ru8), cyclohexyl (Ru9), 4-Cl-phenyl (10), 4-Br-phenyl (Ru11), and 4-EtO-phenyl (Ru12), tsc=thiosemicarbazone) were prepared and characterized by elemental analysis, FTIR, (1)H-NMR and FAB-MS. Effect of these complexes on the growth of a transplantable murine tumor cell line (Ehrlich Ascites Carcinoma) and their antibacterial activity were studied. In cancer study the effect of hematological profile of the tumor hosts have also been studied. In the cancer study, the complexes Ru1-Ru4, Ru10 and Ru11 have remarkably decreased the tumor volume and viable ascitic cell count as indicated by trypan blue dye exclusion test (p<0.05). Treatment with the ruthenium complexes prolonged the lifespan of Ehrlich Ascites Carcinoma (EAC) bearing mice. Tumor inhibition by the ruthenium chelates was followed by improvements in hemoglobin, RBC and WBC values. All the complexes showed antibacterial activity, except Ru5 and Ru6. Thus, the results suggest that these ruthenium complexes have significant antitumor property and antibacterial activity. The results also reflect that the drug does not adversely affect the hematological profiles as compared to that of cisplatin on the host.     

Synthesis of mononuclear and dinuclear ruthenium(II) tris(heteroleptic) complexes via photosubstitution in bis(carbonyl) precursors

A novel, and quite general, approach for the preparation of tris(heteroleptic) ruthenium(II) complexes is reported. Using this method, which is based on photosubstitution of carbonyl ligands in precursors such as [Ru(bpy)(CO)(2)Cl(2)] and [Ru(bpy)(Me(2)bpy)(CO)(2)](PF(6))(2), mononuclear and dinuclear Ru(II) tris(heteroleptic) polypyridyl complexes containing the bridging ligands 3,5-bis(pyridin-2-yl)-1,2,4-triazole (Hbpt) and 3,5-bis(pyrazin-2-yl)-1,2,4-triazole (Hbpzt) have been prepared. The complexes obtained were purified by column chromatography and characterized by HPLC, mass spectrometry, 1H NMR, absorption and emission spectroscopy and by electrochemical methods. The X-ray structures of the compounds [Ru(bpy)(Me(2)bpy)(bpt)](PF(6))x0.5C(4)H(10)O [1x0.5C(4)H(10)O], [Ru(bpy)(Me(2)bpy)(bpzt)](PF(6))xH(2)O (2xH(2)O) and [Ru(bpy)(Me(2)bpy)(CH(3)CN)(2)](PF(6))(2)xC(4)H(10)O (6xC(4)H(10)O) are reported. The synthesis and characterisation of the dinuclear analogues of 1 and 2, [{Ru(bpy)(Me(2)bpy)}(2)bpt](PF(6))(3)x2H(2)O (3) and [{Ru(bpy)(Me(2)bpy)}(2)bpzt](PF(6))(3) (4), are also described.     

Ruthenium(II)-polyazine light absorbers bridged to reactive cis-dichlororhodium(III) centers in a bimetallic molecular architecture

Bimetallic complexes of the form [(bpy)(2)Ru(BL)RhCl(2)(phen)](PF(6))(3), where bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, and BL = 2,3-bis(2-pyridyl)pyrazine (dpp) or 2,2'-bipyrimidine (bpm), were synthesized, characterized, and compared to the [{(bpy)(2)Ru(BL)}(2)RhCl(2)](PF(6))(5) trimetallic analogues. The new complexes were synthesized via the building block method, exploiting the known coordination chemistry of Rh(III) polyazine complexes. In contrast to [{(bpy)(2)Ru(dpp)}(2)RhCl(2)](PF(6))(5) and [{(bpy)(2)Ru(bpm)}(2)RhCl(2)](PF(6))(5), [(bpy)(2)Ru(dpp)RhCl(2)(phen)](PF(6))(3) and [(bpy)(2)Ru(bpm)RhCl(2)(phen)](PF(6))(3) have a single visible light absorber subunit coupled to the cis-Rh(III)Cl(2) moiety, an unexplored molecular architecture. The electrochemistry of [(bpy)(2)Ru(dpp)RhCl(2)(phen)](PF(6))(3) showed a reversible oxidation at 1.61 V (vs Ag/AgCl) (Ru(III/II)), quasi-reversible reductions at -0.39 V, -0.74, and -0.98 V. The first two reductive couples corresponded to two electrons, consistent with Rh reduction. The electrochemistry of [(bpy)(2)Ru(bpm)RhCl(2)(phen)](PF(6))(3) exhibited a reversible oxidation at 1.76 V (Ru(III/II)). A reversible reduction at -0.14 V (bpm(0/-)), and quasi-reversible reductions at -0.77 and -0.91 V each corresponded to a one electron process, bpm(0/-), Rh(III/II), and Rh(II/I). The dpp bridged bimetallic and trimetallic display Ru(dpi)-->dpp(pi*) metal-to-ligand charge transfer (MLCT) transitions at 509 nm (14,700 M(-1) cm(-1)) and 518 nm (26,100 M(-1) cm(-1)), respectively. The bpm bridged bimetallic and trimetallic display Ru(dpi)-->bpm(pi*) charge transfer (CT) transitions at 581 nm (4,000 M(-1) cm(-1)) and 594 nm (9,900 M(-1) cm(-1)), respectively. The heteronuclear complexes [(bpy)(2)Ru(dpp)RhCl(2)(phen)](PF(6))(3) and [{(bpy)(2)Ru(dpp)}(2)RhCl(2)](PF(6))(5) had (3)MLCT emissions that are Ru(dpi)-->dpp(pi*) CT in nature but were red-shifted and lower intensity than [(bpy)(2)Ru(dpp)Ru(bpy)(2)](PF(6))(4). The lifetimes of the (3)MLCT state of [(bpy)(2)Ru(dpp)RhCl(2)(phen)](PF(6))(3) at room temperature (30 ns) was shorter than [(bpy)(2)Ru(dpp)Ru(bpy)(2)](PF(6))(4), consistent with favorable electron transfer to Rh(III) to generate a metal-to-metal charge-transfer ((3)MMCT) state. The reported synthetic methods provide means to a new molecular architecture coupling a single Ru light absorber to the Rh(III) center while retaining the interesting cis-Rh(III)Cl(2) moiety.     

Diastereoselective preparation and characterization of ruthenium bis(bipyridine) sulfoxide complexes

A new concept in the synthesis of optically active octahedral ruthenium complexes was realized for the first time when cis- or trans-Ru(bpy)2Cl, (cis- or trans-1) was reacted with either (R)-(+)- or (S)-(-)-methyl p-tolyl sulfoxide (2 or 3); this novel asymmetric synthesis leads to the diastereoselective formation of the ruthenium bis(bipyridine) complex cis-delta-[Ru(bpy)2(2)Cl]Cl (4) (49.6% de) or cis-lambda-[Ru(bpy)2(3)Cl]Cl (5) (48.4% de), respectively. cis- or trans-Ru(dmbpy)2Cl2 (cis- or trans-6) (dmbpy = 4,4'-dimethyl-2,2'-bipyridine) also reacts with 2 or 3, leading to the diastereoselective formation of cis-delta-[Ru(dmbpy)2(2)Cl]Cl (7) (59.5% de) or cis-lambda-[Ru(dmbpy)2(3)Cl]Cl (8) (57.2% de), respectively. The diastereoselectivity of these reactions is governed solely by the chirality of the sulfoxide nucleophile. This represents the first process by which a sigma-bonded ligand occupying only a single coordination site has had such an important influence on the stereochemical outcome of a ruthenium bis(bipyridine) complex formation. These novel complexes were fully characterized by elemental analysis and IR, UV/vis, and 1H, 13C, and 2D NMR spectroscopy. An investigation into the chiroptical properties of these novel ruthenium bis(bipyridine) sulfoxide complexes has been carried out, and circular dichroism spectra are used to assign absolute stereochemistry.     

Ruthenium(II) polypyridyl complexes as carriers for DNA delivery

Two novel water soluble ruthenium(II) complexes [Ru(bpy)(2)(bqbg)](2+) and [Ru(phen)(2)(bqbg)](2+) have been structurally characterized and their DNA condensation activity, cytotoxicity, and cellular uptake studies of DNA condensates as potential non-viral DNA carriers were evaluated.     

Synthesis, characterization, and photochemical and computational investigations of Ru(II) heterocyclic complexes containing 2,6-dimethylphenylisocyanide (CNx) ligand

The isocyanide ligand forms complexes with ruthenium(II) bis-bipyridine of the type [Ru(bpy)(2)(CNx)Cl](CF(3)SO(3)) (1), [Ru(bpy)(2)(CNx)(py)](PF(6))(2) (2), and [Ru(bpy)(2)(CNx)(2)](PF(6))(2) (3) (bpy = 2,2'-bipyridine, py = pyridine, and CNx = 2,6-dimethylphenylisocyanide). The redox potentials shift positively as the number of CNx ligands increases. The metal-to-ligand charge-transfer (MLCT) bands of the complexes are located at higher energy than 450 nm and blue shift in proportion to the number of CNx ligands. The complexes are not emissive at room temperature but exhibit intense structured emission bands at 77 K with emission lifetimes as high as 25 micros. Geometry optimization of the complexes in the singlet ground and lowest-lying triplet states performed using density functional theory (DFT) provides information about the orbital heritage and correlates with X-ray and electrochemical results. The lowest-lying triplet-state energies correlate well with the 77 K emission energies for the three complexes. Singlet excited states calculated in ethanol using time-dependent density functional theory (TDDFT) and the conductor-like polarizable continuum model (CPCM) provide information that correlates favorably with the experimental absorption spectra in ethanol.     

Bis(amido)ruthenium(IV) Complexes with 2,3-Diamino-2,3-dimethylbutane. Crystal Structure and Reversible Ru(IV)-Amide/Ru(III)-Amine and Ru(IV)-Amide/Ru(II)- Amine Redox Couples in Aqueous Solution

Two bis(amido)ruthenium(IV) complexes, [Ru(IV)(bpy)(L-H)(2)](2+) and [Ru(IV)(L)(L-H)(2)](2+) (bpy = 2,2'-bipyridine, L = 2,3-diamino-2,3-dimethylbutane, L-H = (H(2)NCMe(2)CMe(2)NH)(-)), were prepared by chemical oxidation of [Ru(II)(bpy)(L)(2)](2+) and the reaction of [(n-Bu)(4)N][Ru(VI)NCl(4)] with L, respectively. The structures of [Ru(bpy)(L-H)(2)][ZnBr(4)].CH(3)CN and [Ru(L)(L-H)(2)]Cl(2).2H(2)O were determined by X-ray crystal analysis. [Ru(bpy)(L-H)(2)][ZnBr(4)].CH(3)CN crystallizes in the monoclinic space group P2(1)/n with a = 12.597(2) ?, b = 15.909(2) ?, c = 16.785(2) ?, beta = 91.74(1) degrees, and Z = 4. [Ru(L)(L-H)(2)]Cl(2).2H(2)O crystallizes in the tetragonal space group I4(1)/a with a = 31.892(6) ?, c = 10.819(3) ?, and Z = 16. In both complexes, the two Ru-N(amide) bonds are cis to each other with bond distances ranging from 1.835(7) to 1.856(7) ?. The N(amide)-Ru-N(amide) angles are about 110 degrees. The two Ru(IV) complexes are diamagnetic, and the chemical shifts of the amide protons occur at around 13 ppm. Both complexes display reversible metal-amide/metal-amine redox couples in aqueous solution with a pyrolytic graphite electrode. Depending on the pH of the media, reversible/quasireversible 1e(-)-2H(+) Ru(IV)-amide/Ru(III)-amine and 2e(-)-2H(+) Ru(IV)-amide/Ru(II)-amine redox couples have been observed. At pH = 1.0, the E degrees is 0.46 V for [Ru(IV)(bpy)(L-H)(2)](2+)/[Ru(III)(bpy)(L)(2)](3+) and 0.29 V vs SCE for [Ru(IV)(L)(L-H)(2)](2+)/[Ru(III)(L)(3)](3+). The difference in the E degrees values for the two Ru(IV)-amide complexes has been attributed to the fact that the chelating saturated diamine ligand is a better sigma-donor than 2,2'-bipyridine.     

Eilatin as a bridging ligand in ruthenium(II) complexes: synthesis,crystal structures,absorption spectra,and electrochemical properties

The potential of the heptacyclic aromatic alkaloid eilatin (1), that features two nonequivalent binding sites, to serve as a bridging ligand is reported. The nonequivalency of the binding sites allowed the selective synthesis of both mono- and dinuclear complexes. The mononuclear Ru(II) complexes [Ru(dmbpy)(2)(eilatin)](2+) (2) and [Ru(tmbpy)(2)(eilatin)](2+) (3) in which eilatin selectively binds "head-on" were synthesized and employed as building blocks in the synthesis of the dinuclear complexes [[Ru(dmbpy)(2)](2)(mu-eilatin)](4+) (4) and [[Ru(tmbpy)(2)](2)(mu-eilatin)](4+) (5). Complete structure elucidation of the complexes in solution was accomplished by 1D and 2D NMR techniques. The X-ray structures of the mononuclear complex 3 and of the two dinuclear complexes 4 and 5 were solved, and absorption spectra and electrochemical properties of the complexes were explored. Both dinuclear complexes formed as racemic mixtures in a 3:1 diastereoisomeric ratio, the major isomer being the heterochiral one (Delta Lambda/Lambda Delta) as revealed by crystallography. The mononuclear complexes feature an exceptionally low energy MLCT band around 600 nm that shifted to over 700 nm upon the binding of the second Ru(II) center. The mononuclear complexes show one reversible oxidation and several reversible reduction waves, the first two reductions being substantially anodically shifted in comparison with [Ru(bpy)(3)](2+), attributed to the reduction of eilatin, and consistent with its low lying pi* orbital. The dinuclear complexes follow the same reduction trend, exhibiting several reversible reduction waves, and two reversible well-resolved metal centered oxidations due to the nonequivalent binding sites and to a significant metal-metal interaction mediated by the bridging eilatin.     

Synthesis, structure, spectroscopic properties, and electrochemical oxidation of ruthenium(II) complexes Incorporating monocarboxylate bipyridine ligands

[Ru(bpy)(2)(Mebpy-COOH)](PF(6))(2).3H(2)O (1), [Ru(phen)(2)(Mebpy-COOH)](ClO(4))(2).5H(2)O (2), [Ru(dppz)(2)(Mebpy-COOH)]Cl(2).9H(2)O (3), and [Ru(bpy)(dppz)(Mebpy-COOH)](PF(6))(2).5H(2)O (4) (bpy = 2,2'-bipyridine, Mebpy-COOH = 4'-methyl-2,2'-bipyridine-4-carboxylic acid, phen = 1,10-phenanthroline, dppz = dipyrido[3,2,-a;2',3-c]phenazine) have been synthesized and characterized spectroscopically and by microanalysis. The [Ru(Mebpy-COOH)(CO)(2)Cl(2)].H(2)O intermediate was prepared by reaction of the monocarboxylic acid ligand, Mebpy-COOH, with [Ru(CO)(2)Cl(2)](n), and the product was then reacted with either bpy, phen, or dppz in the presence of an excess of trimethylamine-N-oxide (Me(3)NO), as the decarbonylation agent, to generate 1, 2, and 3, respectively. For compound 4, [Ru(bpy)(CO)Cl(2)](2) was reacted with Mebpy-COOH to yield [Ru(bpy)(Mebpy-COOH)(CO)Cl](PF(6)).H(2)O as a mixture of two main geometric isomers. Chemical decarbonylation in the presence of dppz gave 4 also as a mixture of two isomers. Electrochemical and spectrophotometric studies indicated that complexes 1 and 2 were present as a mixture of protonated and deprotonated forms in acetonitrile solution because of water of solvation in the isolated solid products. The X-ray crystal structure determination on crystals of [Ru(bpy)2(MebpyCOO)][Ru(bpy)(2)(MebpyCOOH)](3)(PF(6))(7), 1a, and [Ru(phen)(2)(MebpyCOO)](ClO(4)).6H(2)O, 2a, obtained from solutions of 1 and 2, respectively, revealed that 1a consisted of a mixture of protonated and deprotonated forms of the complex in a 1:3 ratio and that 2a consisted of the deprotonated derivative of 2. A distorted octahedral geometry for the Ru(II) centers was found for both complexes. Upon excitation at 450 nm, MeCN solutions of the protonated complexes 1-4 were found to exhibit emission bands in the 635-655 nm range, whereas the corresponding emission maxima of their deprotonated forms were observed at lower wavelengths. Protonation/deprotonation effects were also observed in the luminescence and electrochemical behavior of complexes 1-4. Comprehensive electrochemical studies in acetonitrile show that the ruthenium centers on 1, 2, 3, and 4 are oxidized from Ru(II) to Ru(III) with reversible potentials at 917, 929, 1052, and 1005 mV vs Fc(0/+) (Fc = ferrocene), respectively. Complexes 1 and 2 also exhibit an irreversible oxidation process in acetonitrile, and all compounds undergo ligand-based reduction processes.     

Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity

A series of mixed ligand ruthenium(II) complexes [Ru(pdto)(diimine)](ClO4)2/(PF6)2 1-3 and [Ru(bbdo)(diimine)](ClO4), 4-6, where pdto is 1,8-bis(pyrid-2-yl)-3,6-dithiooctane, bbdo is 1,8-bis(benzimidazol-2-yl)-3,6-dithiooctane and diimine is 1,10-phenanthroline (phen), dipyrido-[3,2-d:2',3'-f]-quinoxaline (dpq) and dipyrido[3,2-a:2',3'-c]phenazine (dppz), have been isolated and characterised by analytical and spectral methods. The complexes [Ru(pdto)(phen)](PF6)2 la, [Ru(pdto)(dpq)(Cl](PF6) 2a, [Ru(bbdo)(phen)](PF6)2 4a and [Ru(bbdo)(dpq)](ClO4)2 5 have been structurally characterized and their coordination geometries around ruthenium(II) are described as distorted octahedral. In la, 4a and 5 the two thioether sulfur and two py/bzim nitrogen atoms of the tetradentate pdto/bbdo ligand are folded around Ru(II) to give predominantly a "cis-alpha" configuration. (I)H NMR spectral data of the complexes support this configuration in solution. In [Ru(pdto)(dpq)Cl](PF6) 2a with a distorted octahedral coordination geometry, one of the two py nitrogens of pdto is not coordinated. The DNA binding constants (Kb: 2, 2.00 +/- 0.02 x 10(4) M(-1), s = 1.0; 3, 3.00 +/- 0.01 x 10(6) M(-1), s = 1.3) determined by absorption spectral titrations of the complexes with CT DNA reveal that 3 interacts with DNA more tightly than 2 through partial intercalation of the extended planar ring of coordinated dppz with the DNA base stack. The DNA binding affinities of the complexes increase with increase in the number of planar aromatic rings in the co-ligand, and on replacing both the py moieties in pdto complexes (1-3) by bzim moieties to give bbdo complexes (4-6). Upon interaction with CT DNA the complexes 1, 2, 5 and 6 show a decrease in anodic current in the cyclic voltammograms. On the other hand, interestingly, 3 and 4 show an increase in anodic current suggesting their involvement in electrocatalytic guanine oxidation. Interestingly, of all the complexes, only 6 alters the superhelicity of DNA upon binding with supercoiled pBR322 DNA. The cytotoxicities of the dppz complexes 3 and 6, which avidly bind to DNA, have been examined by screening them against cell lines of different cancer origins. It is noteworthy that 6 exhibits selectivity with higher cytotoxicity against the melanoma cancer cell line (A375) than other cell lines, potency approximately twice that of cisplatin and toxicity to normal cells 3 and 90 times less than cisplatin and adriamycin respectively.     

The inducing NO-vasodilation by chemical reduction of coordinated nitrite ion in cis-[Ru(NO(2))L(bpy)(2)](+) complex

The synthesis of [Ru(NO(2))L(bpy)(2)](+) (bpy = 2,2'-bipyridine and L = pyridine (py) and pyrazine (pz)) can be accomplished by addition of [Ru(NO)L(bpy)(2)](PF(6))(3) to aqueous solutions of physiological pH. The electrochemical processes of [Ru(NO(2))L(bpy)(2)](+) in aqueous solution were studied by cyclic voltammetry and differential pulse voltammetry. The anodic scan shows a peak around 1.00 V vs. Ag/AgCl attributed to the oxidation process centered on the metal ion. However, in the cathodic scan a second peak around -0.60 V vs. Ag/AgCl was observed and attributed to the reduction process centered on the nitrite ligand. The controlled reduction potential electrolysis at -0.80 V vs. Ag/AgCl shows NO release characteristics as judged by NO measurement with a NO-sensor. This assumption was confirmed by ESI/MS(+) and spectroelectrochemical experiment where cis-[Ru(bpy)(2)L(H(2)O)](2+) was obtained as a product of the reduction of cis-[Ru(II)(NO(2))L(bpy)(2)](+). The vasorelaxation observed in denuded aortic rings pre-contracted with 0.1 mumol L(-1) phenylephrine responded with relaxation in the presence of cis-[Ru(II)(NO(2))L(bpy)(2)](+). The potential of rat aorta cells to metabolize cis-[Ru(II)(NO(2))L(bpy)(2)](+) was also followed by confocal analysis. The obtained results suggest that NO release happens by reduction of cis-[Ru(II)(NO(2))L(bpy)(2)](+) inside the cell. The maximum vasorelaxation was achieved with 1 x 10(-5) mol L(-1) of cis-[Ru(II)(NO(2))L(bpy)(2)](+) complex.